HaploAnco Hereditary Tumor Gene Detection

Genetic screening for hereditary cancer susceptibility genes including BRCA and other tumor suppressors. This test enables early identification of high-risk individuals for surveillance.

A molecular detection kit for identifying hereditary disease markers and genetic predispositions. Designed for clinical screening and diagnostic purposes in genetic medicine applications.

A comprehensive genetic testing panel designed for detecting genetic variations associated with hereditary diseases and health conditions. The panel utilizes advanced sequencing technology for precise variant identification.

Diagnostic test for identifying genetic disorders through molecular analysis of biological samples. The test can detect chromosomal abnormalities and inherited genetic conditions.

Blood test panel for detecting and characterizing genetic and epigenetic mutations in circulating tumor DNA. Helps determine cancer origin, measure tumor burden, and identify new mutations during targeted therapy treatment.

Ultra-high sensitivity early detection kit designed to identify cancer gene mutations. Enables early-stage cancer diagnosis through advanced genetic analysis technology.

A molecular assay for the detection of specific genetic sequences or mutations in patient samples. The test is used in genetic screening, disease diagnosis, and personalized medicine applications.

Molecular diagnostic kit for identification of specific genetic mutations associated with disease or resistance. Enables targeted diagnostic and therapeutic decision-making.

PCR-based kits designed to detect specific gene mutations and polymorphisms associated with malignancy. These products enable targeted molecular analysis for precision tumor diagnosis.

In vitro diagnostic kit for detecting gene polymorphisms associated with neural tube defects through molecular analysis. Enables risk assessment and genetic screening in prenatal and family planning contexts. Supports personalized medicine approaches for birth defect prevention.

Molecular diagnostic test using CRISPR/Cas9 technology to identify and amplify mutant DNA sequences in patient samples. Provides standardized detection and quantification of cancer-related genetic mutations.

Molecular assay reagents (primers and probes) that detect EGFR gene mutations in tissue DNA and plasma cfDNA, including the EGFR-19del variant common in Asian non-small cell lung cancer patients.